Pitavastatin is a statin drug that, by competitively inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase, can decrease serum levels of cholesterol of low-density lipoprotein (LDL) accompanied by negative effects attributable to pleiotropic results resulting in statin intolerance. These results might be defined by the lipophilicity of statins, which creates membrane affinity and causes statin localization in mobile membranes. […]
